On Tuesday, Evogene Ltd (NASDAQ: EVGN) was 6.35% up from the session before settling in for the closing price of $1.25. A 52-week range for EVGN has been $0.95 – $2.87.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 16.27%. When this article was written, the company’s average yearly earnings per share was at 25.61%. With a float of $8.58 million, this company’s outstanding shares have now reached $8.71 million.
The extent of productivity of a business whose workforce counts for 117 workers is very important to gauge.
Evogene Ltd (EVGN) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Evogene Ltd stocks. The insider ownership of Evogene Ltd is 1.56%, while institutional ownership is 2.23%.
Evogene Ltd (EVGN) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -1.31 earnings per share (EPS) during the time that was less than consensus figure (set at -1.01) by -0.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.50% during the next five years compared to 16.27% growth over the previous five years of trading.
Evogene Ltd (NASDAQ: EVGN) Trading Performance Indicators
You can see what Evogene Ltd (EVGN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.25, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.10 in one year’s time.
Technical Analysis of Evogene Ltd (EVGN)
The latest stats from [Evogene Ltd, EVGN] show that its last 5-days average volume of 0.15 million was inferior to 0.74 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 79.20%.
During the past 100 days, Evogene Ltd’s (EVGN) raw stochastic average was set at 19.81%, which indicates a significant decrease from 99.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0595 in the past 14 days, which was lower than the 0.0821 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2332, while its 200-day Moving Average is $1.3357. Now, the first resistance to watch is $1.3729. This is followed by the second major resistance level at $1.4165. The third major resistance level sits at $1.5029. If the price goes on to break the first support level at $1.2429, it is likely to go to the next support level at $1.1565. The third support level lies at $1.1129 if the price breaches the second support level.
Evogene Ltd (NASDAQ: EVGN) Key Stats
There are 5,365K outstanding shares of the company, which has a market capitalization of 11.58 million. As of now, sales total 8,510 K while income totals -16,490 K. Its latest quarter income was 880 K while its last quarter net income were -4,460 K.
